Nasus Pharma NSRX
NYSE NSRX
$3.40 +0.16 (+4.65%)
As of: Oct 21, 2026 · 11:35 AM EDT

Nasus Pharma (NSRX) Total Liabilities (2024 - 2026)

Updated

Nasus Pharma (NSRX) reported Total Liabilities of $1.45 million for Q2 2026, down 70.7% from $4.95 million a year earlier.

Analysis

Nasus Pharma (NSRX) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma posted Total Liabilities of $2.24 million, down 43.1% from FY2024.

  • By year, Total Liabilities came in at $3.93 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 116.09 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 141.05 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 65.46 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 37.53 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 115.64 Bn
10 Nasus Pharma 27.23 Mn 10.53 Mn - 1.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.45 Mn
Dec 31, 2025 2.24 Mn
Jun 30, 2025 4.95 Mn
Dec 31, 2024 3.93 Mn
API Access

Nasus Pharma Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NSRX&period=max&api_key=YOUR_API_KEY